Published in Medical Letter on the CDC and FDA, July 15th, 2007
Cell Works Inc., a Maryland-based biotech company, had focused on developing cancer therapeutics and diagnostics tools. Currently six U.S. medical patents are for sale, including one associated with a liver cancer therapeutic drug that has already been granted orphan drug status by the Food and Drug Administration (FDA). Also included in the sale are 24 foreign patents.
Company Summary: Cell Works Inc. developed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.